New vaccine aims to shield chinese families from pneumococcal disease
NCT ID NCT07023081
First seen Jan 08, 2026 · Last updated May 20, 2026 · Updated 24 times
Summary
This study tests a new vaccine that protects against 20 types of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. Around 200 healthy Chinese adults, children, and infants will receive the vaccine according to their age group. Researchers will monitor for side effects and measure immune responses to ensure the vaccine is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Nanning, Guangxi, 530021, China
-
Wuming District Center for Disease Control and Prevention
Chengxiang, Nanning, 530199, China
Conditions
Explore the condition pages connected to this study.